Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, ra...

por Donohue, James F, Niewoehner, Dennis, Brooks, Jean, O’Dell, Dianne, Church, Alison
Publicado 2014

Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

por Kalberg, Chris, O’Dell, Dianne, Galkin, Dmitry, Newlands, Amy, Fahy, William A.
Publicado 2016

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD

por Siler, Thomas M, Donald, Alison C, O’Dell, Dianne, Church, Alison, Fahy, William A
Publicado 2016